Covered recipient · General Payments record
ANNA H POWELL
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$5,478.70
- Reported across 316 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $504.71 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $161.46 | 10 |
| ABBVIE INC. | $75.54 | 4 |
| PFIZER INC. | $51.33 | 2 |
| KVK-Tech, Inc. | $44.62 | 1 |
| Amgen Inc. | $39.76 | 2 |
| Lilly USA, LLC | $37.74 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $26.13 | 1 |
| Exact Sciences Corporation | $22.06 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $16.55 | 1 |
| Astellas Pharma US Inc | $15.66 | 1 |
| Phathom Pharmaceuticals, Inc. | $13.86 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.83 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105303049 | CMS |
| ABBVIE INC. | $13.95 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105303053 | CMS |
| ABBVIE INC. | $18.08 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105303057 | CMS |
| ABBVIE INC. | $24.68 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105303061 | CMS |
| Amgen Inc. | $19.93 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117356530 | CMS |
| Amgen Inc. | $19.83 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117356532 | CMS |
| Astellas Pharma US Inc | $15.66 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139312024 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $26.13 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117969356 | CMS |
| Exact Sciences Corporation | $22.06 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114839867 | CMS |
| KVK-Tech, Inc. | $44.62 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1063934184 | CMS |
| Lilly USA, LLC | $16.91 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136057352 | CMS |
| Lilly USA, LLC | $20.83 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136048475 | CMS |
| Novartis Pharmaceuticals Corporation | $16.55 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087285677 | CMS |
| Novo Nordisk Inc | $14.15 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096930014 | CMS |
| Novo Nordisk Inc | $19.47 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096616954 | CMS |
| Novo Nordisk Inc | $19.30 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096573436 | CMS |
| Novo Nordisk Inc | $13.51 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096573360 | CMS |
| Novo Nordisk Inc | $18.32 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096797130 | CMS |
| Novo Nordisk Inc | $16.09 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097305088 | CMS |
| Novo Nordisk Inc | $15.69 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096892971 | CMS |
| Novo Nordisk Inc | $19.62 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096958944 | CMS |
| Novo Nordisk Inc | $21.47 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097725432 | CMS |
| Novo Nordisk Inc | $3.84 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097561117 | CMS |
| PFIZER INC. | $29.46 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131177704 | CMS |
| PFIZER INC. | $21.87 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131752240 | CMS |
| Phathom Pharmaceuticals, Inc. | $13.86 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151111656 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.